echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Ministry of Finance: The new direction of drug companies checking accounts has come

    Ministry of Finance: The new direction of drug companies checking accounts has come

    • Last Update: 2021-01-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    1 Check the new direction Yesterday (January 25), the Ministry of Finance of the People's Republic of China published an article "Shandong Supervision Bureau of the Ministry of Finance: Planning layout clear direction accounting supervision of the new chapter", the future of accounting supervision work to further clarify the direction.
    future, Shandong Province will strengthen accounting supervision as an opportunity to complete the six key tasks of accounting supervision, in accounting supervision to achieve a new breakthrough.
    it is mentioned that the establishment and improvement of the daily supervision mechanism of public interest entities that have a significant impact on social and economic development, such as central enterprises, local key state-owned enterprises and listed companies, and the acceleration of the construction of the basic database of accounting supervision objects.
    In addition, the meeting showed that the use of accounting information quality inspection means, focusing on key enterprises as well as large-scale business, high-risk accounting firms and asset assessment institutions, the annual report audit irregularities and corporate accounting fraud serious punishment.
    around the six key tasks, the relevant departments through the "four combination" of accounting supervision work responsibilities in place, one is to adhere to the point of integration, to achieve full coverage of the scope of supervision.
    focus on the selection of 50 enterprises with high social concern related to the national economy and people's livelihood, such as in Lu central enterprises, local key state-owned enterprises, listed companies and other public interest entities, to carry out daily supervision.
    anatomy of a point, stringing together an industry line, affecting a face of the region.
    , we should adhere to the combination of daily supervision and special inspection to improve the relevance and effectiveness of supervision.
    effectively improve the efficiency of supervision by distinguishing between key enterprises and general enterprises.
    Select key enterprises to carry out all-round, multi-dimensional daily supervision, comprehensive use of talks, interviews, interviews, questionnaires, big data analysis and other means to find industry-wide, trending, seed problems, for special inspection to provide clues and guidance.
    to the deep-seated problems found in the special inspection, the implementation of breakthroughs, involving policy implementation, standard implementation and institutional loopholes, active thinking, in-depth discussion, to provide the Ministry of Finance with decision-making basis.
    2 The quality supervision of accounting information in the pharmaceutical industry has already begun to be issued by the Ministry of Finance, which determines the direction of the quality inspection of accounting information, combined with the relevant documents issued by the state before, which means that the supervision and inspection of the accounting information of pharmaceutical enterprises in the future, that is, the accounting of pharmaceutical enterprises, has determined a new direction.
    2020, the General Office of the State Council issued the Guidance on Promoting the Reform of the Regulatory System of the Health Care Fund.
    , article 17 of the National People's Congress clearly states that the market-oriented price formation mechanism for pharmaceuticals and medical supplies has been continuously improved, and the mechanism for linking the payment of medical insurance with the price of tender and purchase has been improved.
    strengthen the quality supervision and inspection of accounting information in the pharmaceutical industry, and carry out in-depth special management of the inflated prices of pharmaceutical and high-value medical supplies.
    June 2019, the Ministry of Finance also issued an urgent document, "The Ministry of Finance on the implementation of the 2019 pharmaceutical industry accounting information quality inspection notice" financial supervision (2019) No. 18.
    Select 77 pharmaceutical enterprises to carry out quality inspection of accounting information, including innovative pharmaceutical enterprises, generic pharmaceutical enterprises, traditional Chinese pharmaceutical enterprises and other types of enterprises, intended to analyze the cost and profit composition of drugs from production to sales in all aspects, reveal the drug price formation mechanism, for the comprehensive management of drug prices, to solve the people's "expensive to see a doctor" problem to provide the first information.
    Not long after, the Shandong Regulatory Bureau of the Ministry of Finance held a meeting in the city of Luze, stressing the importance of the quality inspection of accounting information in the pharmaceutical industry, pointing out that inspection is an urgent need to promote the reform of the medical and health system, an important measure to deepen the structural reform on the supply side, and a realistic requirement for the implementation of the Accounting Law, the rectification and standardization of the market economic order.
    focus on the pharmaceutical sales link to carry out "penetrating" supervision, extended inspection of related parties and related sales, agents, advertising, consulting and other institutions, if necessary, check the arrangements of medical institutions, as well as costs, costs, income authenticity.
    Combined with the above-mentioned documents, if the real cost of different types of pharmaceutical companies to find out the marketing costs, in order to squeeze out the price of the drug moisture preparation, so as to bring pressure for the relevant drugs to reduce prices of 77 pharmaceutical companies to check the accounts, is an emergency This time, the Ministry of Finance issued a paper, the Ministry of Finance Shandong Regulatory Bureau's regulatory action and regulatory plan as a typical, or means that in the future will be the key listed pharmaceutical companies, large-scale pharmaceutical enterprises to carry out normal accounting, so as to find industry problems, so as to achieve a breakthrough in deep-seated problems.
    3 Anti-corruption, check accounts, two-pronged check the core object of the account - listed pharmaceutical companies, sales costs are difficult to bypass obstacles, after all, high sales is a common feature of the pharmaceutical industry, some enterprises marketing costs as high as 60%, become the focus of accounting objects.
    background, the pharmaceutical industry black swan incidents occur frequently, some listed companies have been found to varying degrees of financial fraud, causing market shocks.
    if the accounting supervision, from the accounts and marketing costs of the perspective of pharmaceutical companies with gold sales, pharmaceutical bribery and other acts to restrain.
    administrative means are also an indispensable link for relevant departments to regulate the behavior of pharmaceutical enterprises.
    , the Central Commission for Discipline Inspection published the Communique of the Fifth Plenary Session of the 19th Central Commission for Discipline Inspection of the Communist Party of China, which also pointed the way for future administrative measures to combat corruption.
    In the tasks of the Central Commission for Discipline Inspection in 2021, including the continuous treatment of corruption and style issues in the fields of education and medical care, old-age social security, ecological and environmental protection, safe production, food and drug safety, law enforcement and justice, and resolutely punish the "umbrella" of black-related evils, and improve the governance mechanism for issues that harm the interests of the masses in the field of people's livelihood. From this point of view, restricting the non-standard sales behavior of pharmaceutical companies will become the focus of the work of relevant departments in the future.
    on the one hand, the pharmaceutical industry to carry out a wide range of financial verification, on the other hand, credit rating, pharmaceutical anti-corruption and other in-depth rectification is also ongoing.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.